CALM Study: Can A Prebiotic Fibre bLend Improve Stress, Mood, and Anxiety?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

156 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-02

Study Completion Date

2026-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial will investigate whether a powdered prebiotic fibre blend can improve perceived stress levels in healthy adults with mild-moderate stress levels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Specialized Nutraceutical for Pre-burnout

NCT04532892

Burn Out Psychological Disturbance

COMPLETED NA

The Effect of Prebiotics on Gastrointestinal Functioning and Metabolism

NCT02491125

Change of Transit or Circulation Obesity

COMPLETED NA

Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors

NCT00644098

People Who Are Overweight or Obesity

COMPLETED PHASE2

Kinetic of Compounds of a Melatonin-based Formulation in Healthy Subjects

NCT05419466

Melatonin Bioavailability

COMPLETED NA

Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol Levels

NCT03739242

Hypercholesterolemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is growing interest in how the gut microbiota interacts with the brain to influence psychological outcomes, particularly stress. Even in otherwise healthy individuals, persistent psychological stress is associated with measurable physiological changes-including elevated cortisol levels, heightened hypothalamic-pituitary-adrenal (HPA) axis reactivity, and systemic low-grade inflammation. These biological signatures are increasingly understood to be shaped, in part, by the composition and activity of the gut microbiota.

In this study, we're investigating how a powdered prebiotic fibre supplement can improve stress levels. You may have heard people refer to this as the 'gut-brain axis'. We'll also be looking at the link between the prebiotic fibre supplement intake and changes in other areas of health, like depression, mood, anxiety, cognition, inflammation, and the gut microbiome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two-arm, double-blind, placebo-controlled randomised trial

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Sponsor

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prebiotic fibre blend

Prebiotic fibre blend, consisting of 10g of a powdered supplement, to be taken daily alongside usual diet for 12 weeks.

Group Type EXPERIMENTAL

Prebiotic fibre blend

Intervention Type DIETARY_SUPPLEMENT

A blend of prebiotic fibres in a powdered supplement form.

Placebo

Placebo will be 10g of maltodextrin powder, to be taken daily alongside usual diet for 12 weeks.

Group Type PLACEBO_COMPARATOR

Maltodextrin powder

Intervention Type DIETARY_SUPPLEMENT

Maltodextrin powder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prebiotic fibre blend

A blend of prebiotic fibres in a powdered supplement form.

Intervention Type DIETARY_SUPPLEMENT

Maltodextrin powder

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-50 years of age
* Capacity to give informed consent to participate in the study
* Able to comply with study requirements and visits
* Meet the range required for mild-moderate stress levels (as assessed by DASS-42 stress subscale)
* Normal or corrected to normal vision and/or hearing

Exclusion Criteria

* Current smoker
* Having food allergies and/or intolerances
* Diagnosis of Type 1 or 2 diabetes or cardiovascular disease or psychiatric or neurological conditions (e.g. schizophrenia, dementia) including eating disorders
* Current or previous diagnosis of depression in past 6 months
* Receiving medications that lower cholesterol, blood pressure, blood glucose levels, or improve insulin sensitivity
* Receiving antidepressant or anti-anxiety medications or treatments
* Receiving hormonal birth control
* Perimenopause or menopause
* Pregnancy, lactation, or an intent to become pregnant during the course of the study
* Continuous antibiotic use for \> 3 days within 1 month prior to enrolment
* Continuous use of weight-loss drug for \> 1 month before screening
* Major change in dietary intake in past month (e.g. excluding whole food groups)
* Currently consuming daily prebiotic or probiotic supplements
* Prior use (\< 6 months) of any blood glucose or cholesterol lowering medication
* Any significant GI condition affecting GI absorption including (but not limited to) inflammatory bowel disease, weight loss surgery, irritable bowel disease.
* End stage renal disease
* Active cancer, or treatment for any cancer, in last 3 years
* Consuming more than 20g of fibre a day as assessed by the 18-item FiberScreen

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No